Detalles de la búsqueda
1.
The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
Exp Neurol
; 282: 99-118, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27163548
2.
Glutamatergic regulation of brain histamine neurons: In vivo microdialysis and electrophysiology studies in the rat.
Neuropharmacology
; 99: 1-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26100446
3.
Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.
J Med Chem
; 58(3): 1159-83, 2015 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25590515
4.
The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease.
PLoS Curr
; 62014 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24558637
Resultados
1 -
4
de 4
1
Próxima >
>>